Hyosung Chemical Past Earnings Performance
Past criteria checks 0/6
Hyosung Chemical's earnings have been declining at an average annual rate of -59.7%, while the Chemicals industry saw earnings growing at 5.2% annually. Revenues have been growing at an average rate of 9.6% per year.
Key information
-59.7%
Earnings growth rate
-58.8%
EPS growth rate
| Chemicals Industry Growth | 13.9% |
| Revenue growth rate | 9.6% |
| Return on equity | -920.9% |
| Net Margin | -10.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Here's Why Hyosung Chemical (KRX:298000) Is Weighed Down By Its Debt Load
Apr 07
What Percentage Of Hyosung Chemical Corporation (KRX:298000) Shares Do Insiders Own?
Mar 10The Hyosung Chemical (KRX:298000) Share Price Is Up 104% And Shareholders Are Boasting About It
Feb 12
Factors Income Investors Should Consider Before Adding Hyosung Chemical Corporation (KRX:298000) To Their Portfolio
Jan 22With A 0.8% Return On Equity, Is Hyosung Chemical Corporation (KRX:298000) A Quality Stock?
Jan 01What You Need To Know About Hyosung Chemical Corporation's (KRX:298000) Investor Composition
Dec 09We're Not Counting On Hyosung Chemical (KRX:298000) To Sustain Its Statutory Profitability
Nov 19Revenue & Expenses Breakdown
How Hyosung Chemical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,919,674 | -301,355 | 77,800 | 20,282 |
| 30 Jun 24 | 2,863,089 | -288,188 | 84,567 | 19,592 |
| 31 Mar 24 | 2,832,457 | -340,574 | 85,834 | 19,679 |
| 31 Dec 23 | 2,791,629 | -348,988 | 84,970 | 20,245 |
| 30 Sep 23 | 2,787,192 | -392,596 | 82,677 | 20,725 |
| 30 Jun 23 | 2,778,325 | -496,359 | 83,721 | 21,109 |
| 31 Mar 23 | 2,820,865 | -441,607 | 81,988 | 21,315 |
| 31 Dec 22 | 2,878,558 | -408,867 | 80,068 | 20,883 |
| 30 Sep 22 | 2,844,996 | -327,852 | 80,575 | 21,615 |
| 30 Jun 22 | 2,803,230 | -167,572 | 78,568 | 21,901 |
| 31 Mar 22 | 2,656,004 | -33,047 | 75,577 | 21,704 |
| 31 Dec 21 | 2,519,965 | 58,416 | 73,734 | 21,783 |
| 30 Sep 21 | 2,347,146 | 91,138 | 70,077 | 20,820 |
| 30 Jun 21 | 2,173,396 | 89,000 | 66,482 | 20,207 |
| 31 Mar 21 | 1,983,570 | 29,218 | 67,079 | 20,200 |
| 31 Dec 20 | 1,817,190 | -11,616 | 66,594 | 20,203 |
| 30 Sep 20 | 1,758,583 | 3,500 | 66,141 | 20,421 |
| 30 Jun 20 | 1,727,094 | 33,793 | 66,411 | 20,710 |
| 31 Mar 20 | 1,785,763 | 75,389 | 63,064 | 20,922 |
| 31 Dec 19 | 1,812,470 | 87,823 | 61,358 | 20,993 |
| 30 Sep 19 | 2,682,221 | 87,809 | 87,875 | 31,581 |
| 31 Dec 18 | 1,914,467 | 34,963 | 59,839 | 23,256 |
Quality Earnings: A298000 is currently unprofitable.
Growing Profit Margin: A298000 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A298000 is unprofitable, and losses have increased over the past 5 years at a rate of 59.7% per year.
Accelerating Growth: Unable to compare A298000's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A298000 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (19.6%).
Return on Equity
High ROE: A298000 has a negative Return on Equity (-920.89%), as it is currently unprofitable.